Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area jak stat signaling egfr'

Search results for: 'research area jak stat signaling egfr'

Items 31-36 of 36

Page
per page
  1. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL
  2. Baricitinib phosphate
    A3222 Baricitinib phosphate
    Summary: JAK1/JAK2 inhibitor
      insoluble in EtOH; insoluble in H2O; ≥172.6 mg/mL
  3. TG101209
    A4145 TG101209
    Summary: JAK2/3 inhibitor
      ≥25.5 mg/mL
  4. Baricitinib (LY3009104, INCB028050)
    A4141 Baricitinib (LY3009104, INCB028050)
     2 Citation
    Summary: JAK1/JAK2 inhibitor,selective orally bioavailable
      insoluble in EtOH; insoluble in H2O; ≥18.57 mg/mL
  5. NSC 33994
    A4514 NSC 33994
    Summary: Selective JAK2 inhibitor
      insoluble in DMSO;insoluble in ethanol
  6. SB1317
    A3794 SB1317
    Summary: CDK,JAK and FLT inhibitor
      insoluble in H2O; ≥44.87 mg/mL

Items 31-36 of 36

Page
per page